Showing posts with label Merck Co.. Show all posts
Showing posts with label Merck Co.. Show all posts
Thursday, March 03, 2011
GTx Ipsen team ends
Memphis-based GTx, backed by Pitt Hyde and others, yesterday announced the end of its toremifine collaboration with Ipsen, which had stepped into the partnership slot after Merck left. The MDN reports.
Labels:
drug development,
GTx Inc.,
Ipsen,
Merck Co.,
pharmaceuticals
Tuesday, November 10, 2009
Nashville's Pitt Hyde?
Over in Memphis, entrepreneur Pitt Hyde (at left) has for decades spurred sales of everything from biotech to batteries. The AutoZone founder and philanthropist helped found MB Venture Partners, Memphis Bioworks and more. For the past few years, there's been a good bit of questioning in Middle Tennessee regarding whence may come comparable leadership in the high-growth, high-tech arenas, apart from healthcare services, where a clutch of Frists have helped spawn so many ventures. Well, one candidate has got to be Harry R. Jacobson, M.D., Vanderbilt's now vice chancellor emeritus for health affairs, an advisor to ICA, a board member at Merck, co-founder of the new Tri-Star TNInvestco fund, and much more. Here's our story covering some of Jacobson's thinking, his entrepreneurial track record and his views on Informatics Corporation of America, ICA, where he's an advisor.
Subscribe to:
Posts (Atom)